Primary evidence. Trusted journalism.
AllSci is a platform for discovering, creating, and communicating scientific knowledge. The AllSci newsroom exists to provide systematic, evidence-based coverage of the ideas, people, companies, technologies, and institutions shaping the global life sciences industry.
Every story begins with primary sources — including AllSci’s structured datasets, scientific publications, clinical trial registries, regulatory filings, company disclosures, patent records, and government announcements.
Editors determine what is covered. AI-assisted workflows help identify stories, organize information, integrate relevant context, and prepare reporting drafts. Every published article is reviewed, verified, and refined by an editor before publication.
Our goal is to deliver fast, systematic, and trustworthy reporting that helps researchers, healthcare professionals, industry leaders, investors, and policymakers understand the scientific, clinical, regulatory, and commercial developments shaping the future of life sciences.
Our editorial principles
- Data-driven
- Every story is grounded in primary evidence, including regulatory filings, clinical trial data, scientific publications, company disclosures, patent records, and other verifiable source material.
- Independent
- We do not advocate for companies, investors, regulators, technologies, or policy positions. Our role is to explain what happened, why it matters, and what the evidence shows.
- Analytical
- We provide context — not just headlines — helping readers understand the scientific, competitive, regulatory, and commercial forces behind every story.
- Transparent
- We are open about our sources, our editorial methods, and the role of AI in our reporting process. Readers should understand where information comes from and how our reporting is produced.
Questions or corrections on a story? Email [email protected].
The AllSci Brief
Systematic R&D and deal news. Daily.